Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Return on Sales (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Return on Sales data on record, last reported at 0.1% in Q4 2025.

  • For Q4 2025, Return on Sales rose 9.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.08%, up 8.0%, while the annual FY2025 figure was 0.05%, 9.0% up from the prior year.
  • Return on Sales reached 0.1% in Q4 2025 per PAHC's latest filing, down from 0.1% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.11% in Q1 2022 and bottomed at 0.1% in Q2 2024.
  • Average Return on Sales over 5 years is 0.04%, with a median of 0.04% recorded in 2022.
  • Peak YoY movement for Return on Sales: skyrocketed 36bps in 2021, then decreased -9bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.1% in 2021, then plummeted by -71bps to 0.03% in 2022, then tumbled by -83bps to 0.01% in 2023, then surged by 102bps to 0.01% in 2024, then surged by 846bps to 0.1% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.1% in Q4 2025, 0.1% in Q3 2025, and 0.05% in Q2 2025.